Cargando…
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278571/ https://www.ncbi.nlm.nih.gov/pubmed/28132647 http://dx.doi.org/10.1186/s13054-016-1594-9 |
| _version_ | 1782502664527937536 |
|---|---|
| author | Aguilar, Gerardo Ferriols, Rafael Lozano, Angels Ezquer, Carlos Carbonell, José A. Jurado, Ana Carrizo, Juan Serralta, Ferran Puig, Jaume Navarro, David Alos, Manuel Belda, F. Javier |
| author_facet | Aguilar, Gerardo Ferriols, Rafael Lozano, Angels Ezquer, Carlos Carbonell, José A. Jurado, Ana Carrizo, Juan Serralta, Ferran Puig, Jaume Navarro, David Alos, Manuel Belda, F. Javier |
| author_sort | Aguilar, Gerardo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5278571 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52785712017-02-03 Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients Aguilar, Gerardo Ferriols, Rafael Lozano, Angels Ezquer, Carlos Carbonell, José A. Jurado, Ana Carrizo, Juan Serralta, Ferran Puig, Jaume Navarro, David Alos, Manuel Belda, F. Javier Crit Care Letter BioMed Central 2017-01-30 /pmc/articles/PMC5278571/ /pubmed/28132647 http://dx.doi.org/10.1186/s13054-016-1594-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Aguilar, Gerardo Ferriols, Rafael Lozano, Angels Ezquer, Carlos Carbonell, José A. Jurado, Ana Carrizo, Juan Serralta, Ferran Puig, Jaume Navarro, David Alos, Manuel Belda, F. Javier Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients |
| title | Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients |
| title_full | Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients |
| title_fullStr | Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients |
| title_full_unstemmed | Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients |
| title_short | Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients |
| title_sort | optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278571/ https://www.ncbi.nlm.nih.gov/pubmed/28132647 http://dx.doi.org/10.1186/s13054-016-1594-9 |
| work_keys_str_mv | AT aguilargerardo optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT ferriolsrafael optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT lozanoangels optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT ezquercarlos optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT carbonelljosea optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT juradoana optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT carrizojuan optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT serraltaferran optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT puigjaume optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT navarrodavid optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT alosmanuel optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients AT beldafjavier optimaldosesofcaspofunginduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients |